These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 15473889)

  • 1. Aldosterone: from integrative physiology to cellular biology and back.
    Ertl G
    Eur J Clin Invest; 2004 Oct; 34(10):653-5. PubMed ID: 15473889
    [No Abstract]   [Full Text] [Related]  

  • 2. Aldosterone-synthase overexpression in heart: a tool to explore aldosterone's effects.
    Heymes C; Garnier A; Fuchs S; Bendall JK; Nehme J; Ambroisine ML; Robidel E; Swynghedauw B; Milliez P; Delcayre C
    Mol Cell Endocrinol; 2004 Mar; 217(1-2):213-9. PubMed ID: 15134820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of aldosterone blockade in heart failure.
    Pitt B
    Heart Fail Clin; 2005 Apr; 1(1):49-56. PubMed ID: 17386833
    [No Abstract]   [Full Text] [Related]  

  • 4. Neurohormones and heart failure: the importance of aldosterone.
    Odedra K; Ferro A
    Int J Clin Pract; 2006 Jul; 60(7):835-46. PubMed ID: 16846401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curriculum in cardiology: Integrated diagnosis and management of diastolic heart failure (Am Heart J 2007;153:189-200).
    Jolobe OM
    Am Heart J; 2007 Jul; 154(1):e5; author reply e7. PubMed ID: 17584543
    [No Abstract]   [Full Text] [Related]  

  • 6. Aldosterone. An important factor in heart failure treatment.
    Mayo Clin Health Lett; 2004 Jul; 22(7):6. PubMed ID: 15237476
    [No Abstract]   [Full Text] [Related]  

  • 7. Aldosterone-induced vasculopathy.
    Struthers AD
    Mol Cell Endocrinol; 2004 Mar; 217(1-2):239-41. PubMed ID: 15134823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aldosterone receptor antagonism in heart failure.
    Jennings DL; Kalus JS; O'Dell KM
    Pharmacotherapy; 2005 Aug; 25(8):1126-33. PubMed ID: 16207104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldosterone synthase inhibitors: pharmacological and clinical aspects.
    Jansen PM; van den Meiracker AH; Jan Danser AH
    Curr Opin Investig Drugs; 2009 Apr; 10(4):319-26. PubMed ID: 19337952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldosterone inhibition and heart failure: too good to be true?
    Francis GS
    Am Heart J; 2001 Jan; 141(1):1-2. PubMed ID: 11136478
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of aldosterone blockade for treatment of heart failure and post-acute myocardial infarction.
    Greenberg B; Zannad F; Pitt B
    Am J Cardiol; 2006 May; 97(10A):34F-40F. PubMed ID: 16698333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldosterone synthase gene polymorphism as a determinant of atrial fibrillation in patients with heart failure.
    Amir O; Amir RE; Paz H; Mor R; Sagiv M; Lewis BS
    Am J Cardiol; 2008 Aug; 102(3):326-9. PubMed ID: 18638595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aldosterone and cardiovascular disease.
    Gaddam KK; Pimenta E; Husain S; Calhoun DA
    Curr Probl Cardiol; 2009 Feb; 34(2):51-84. PubMed ID: 19135616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardioprotection by aldosterone receptor antagonism in heart failure. Part I. The role of aldosterone in heart failure.
    Dieterich HA; Wendt C; Saborowski F
    Fiziol Cheloveka; 2005; 31(6):97-105. PubMed ID: 16366159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aldosterone blockade in patients with heart failure and a reduced left ventricular ejection fraction.
    Pitt B
    Eur Heart J; 2009 Feb; 30(4):387-8. PubMed ID: 19190013
    [No Abstract]   [Full Text] [Related]  

  • 16. Aldosterone receptor antagonism and heart failure: insights from an outpatient clinic.
    Mariotti R; Borelli G; Coceani M; Zingaro S; Barison A; Morelli I; Rondinini L
    J Clin Pharm Ther; 2008 Aug; 33(4):349-56. PubMed ID: 18613852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Associations between aldosterone synthase gene polymorphisms and left ventricular structure and function in Chinese normal Han People].
    Rao L; Zhang Q; Liang W; Huang M; Zhang L
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jan; 34(1):70-1, 74. PubMed ID: 15600184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphism of the aldosterone synthase gene is not associated with progression of diabetic nephropathy, but associated with hypertension in type 2 diabetic patients.
    Ko GJ; Kang YS; Lee MH; Song HK; Kim HK; Cha DR
    Nephrology (Carlton); 2008 Dec; 13(6):492-9. PubMed ID: 18771471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium retention in heart failure and cirrhosis: potential role of natriuretic doses of mineralocorticoid antagonist?
    Bansal S; Lindenfeld J; Schrier RW
    Circ Heart Fail; 2009 Jul; 2(4):370-6. PubMed ID: 19808361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aldosterone synthase gene polymorphism is not associated with gestational hypertension or preeclampsia.
    de Vasconcelos D; Izidoro-Toledo TC; Sandrim VC; Tanus-Santos JE; Palei AC; Cavalli RC
    Clin Chim Acta; 2009 Feb; 400(1-2):139-41. PubMed ID: 19026620
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.